Remedy's Shares Jump 20% After Alan Wake 2 Release

Alan Wake 2 had been highly anticipated by both fans of the first game and horror lovers in general all the way to its release on October 27. It has been received well, and as a result, Remedy Entertainment's shares reached €29.4 ($31) per share on the launch day, climbing 20% compared to the day before. 

At the moment of writing, the price has dropped slightly to €28.65 ($30.2) per share.

Remedy's creative director Sam Lake called Alan Wake 2 its "biggest project yet," and all the work the team had poured into the game in the course of 13 years has paid off it seems, as players are happy with the result. The PS5 version of the new Alan Wake has a Metascore of 89 and a User Score of 8.6 on Metacritic, while the game on PC boasts 91 and 7.5, 95 and 8.3 on Xbox. Some critics even compare it to classics like Resident Evil and Silent Hill.

Alan Wake 2 lets you experience two different visions through the eyes of its protagonists – Alan Wake himself and the FBI agent Saga Anderson. You can switch between the two and uncover new secrets in vastly different worlds.

This success doesn't mean Remedy can take a rest. The studio is working on Control 2, Max Payne 1 and 2 remakes, a Control spin-off codenamed Condor, and an online PvE shooter Vanguard, co-financed by Tencent.

Did you enjoy Alan Wake 2? Share your thoughts about the game, find more numbers here, and join our 80 Level Talent platform and our Telegram channel, follow us on Instagram, Twitter, and LinkedIn, where we share breakdowns, the latest news, awesome artworks, and more.